U.S. Wind Energy: Year in Review

Source: Clean Technica, Zachary Shahan (1/10/11)

"Wind energy made significant advances in 2010."

The American Wind Energy Association (AWEA) recently sent out a news release regarding the industry's 2010 successes and challenges. Of course, no lasting progress was made on a comprehensive national strategy to promote clean energy; but even despite this, wind energy made several significant advances in 2010 and continues to grow in popularity and use.

Here are some notable achievements:

The critical Section 1603 Investment Tax Credit for renewable energy was extended at the end of the year. This policy "is projected to increase wind project installations by roughly 50% each year," Bode noted.
Utility-scale wind energy supplied Iowa with 20% of its electricity in 2010, up from 14% in 2009.
Over 400 U.S. manufacturing plants now serve the wind industry, with plants located and creating jobs in every region of the country.
14 states have installed over 1,000 MW of wind, and a total of 37 states now have at least some utility-scale wind power installed within their borders.
The Obama administration approved Cape Wind, the first offshore wind farm in the nation.
Google announced that it is investing in a massive offshore renewable electricity superhighway, "a project to build 350 miles of transmission off the Atlantic coast from New Jersey to Virginia to tap into gigantic off-shore wind potential."
A Harris poll in October 2010 found 87% of Americans want more wind energy.
Wind energy can be bi-partisan. "President George W. Bush kicked off WINDPOWER 2010 in Dallas last May with a message of perseverance and determination, which rallied the crowd of over 20,000 to action and enthusiasm. The conference is now the largest energy show in the country and brought the ‘think tank' of the industry together, along with political leaders and corporate decision makers.

Novavax Shares Shoot 65% Higher on Phase 3 COVID-19 Vaccine Trial's 89.3% Effectiveness
Source: Streetwise Reports (01/29/2021)

Novavax Inc. shares established a new 52-week high after the firm's COVID-19 vaccine demonstrated an 89.3% efficacy rate in a Phase 3 trial in the U.K. and also showed efficacy against the South African variant in a Phase 2b trial.

Abiomed Shares Gain 8% After Firm Announces Record Q3 Revenue of $232 Million
Source: Streetwise Reports (01/28/2021)

Shares of cardiac medical device maker Abiomed Inc. traded higher after the company reported record revenue for Q3/21 despite the impact from COVID-19.

Sorrento Shares Rise 35% After Firm Posts Positive Data from Phase 1b ICU COVID-19 Trial
Source: Streetwise Reports (01/27/2021)

Shares of Sorrento Therapeutics traded higher after the company released positive preliminary results from it of Phase 1b COVI-MSC™ Study for treatment of hospitalized ICU COVID-19 patients.

Junior Mining Sector 'the Best Value in the Space'
Source: Streetwise Reports (01/27/2021)

The StreetSmart Live! Broadcast on Jan. 26, 2021, focused on metals and why now is a good time for investors to be looking at them and the mining space. John Newell, independent analyst and portfolio manager, and John Feneck, mining sector expert and president of Feneck Consulting, addressed the status of the current metals market. CEOs of the three metals-focused companies comprising the Metallic Group of Companies—Group Ten Metals, Metallic Minerals and Granite Creek Copper—discussed their projects.

Vir Shares Climb 48% on Initial Phase 1 Chronic Hepatitis B Trial Data
Source: Streetwise Reports (01/26/2021)

Vir Biotechnology shares traded higher after the company reported data from its Phase 1 Chronic Hepatitis B Study that showed VIR-3434 significantly and rapidly reduced hepatitis B surface antigen.

Aurinia Pharma Shares Open at 52-Week High as FDA Approves Adult Lupus Nephritis Drug
Source: Streetwise Reports (01/25/2021)

Shares of Aurinia Pharmaceuticals traded 30% higher after the company reported that the U.S. Food and Drug Administration approved its LUPKYNIS™ (voclosporin) for use in treating adults with active lupus nephritis.

AzurRx Doses First Two People in Expanded Phase 2b Trial of Cystic Fibrosis Patients
Source: Streetwise Reports (01/22/2021)

AzurRx BioPharma shares traded 45% higher after the firm advised it had dosed the first two patients in its Phase 2b OPTION 2 Extension Study of MS1819 for treatment of exocrine pancreatic insufficiency in patients with cystic fibrosis.

NGL Energy Shares Rise 21% as It Seeks to Raise $2.05 Billion from Senior Secured Note Offering
Source: Streetwise Reports (01/21/2021)

Shares of NGL Energy Partners LP traded higher after the firm made a series of announcements over the past three days regarding an update on financial operations, a settlement with a customer in bankruptcy, a quarterly Class D unit distribution and a $2.05 billion senior secured debt offering.

Explorer Discovers New Gold Mineralization at Abitibi Gold Belt Property
Source: Streetwise Reports (01/21/2021)

iMetal Resources is setting out to see if the multi-million ounce gold resource next door continues onto its Gowganda West property in Ontario.

Gritstone Oncology Licenses LNP Platform from Genevant Sciences to Develop COVID-19 Vaccine
Source: Streetwise Reports (01/20/2021)

Shares of Gritstone Oncology reached a new 52-week high price after the company advised it entered into a non-exclusive licensing agreement with Genevant Sciences to develop and commercialize self-amplifying RNA vaccines for use against SARS-CoV-2.